|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
6,741,237 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
21,044 |
Total Sell Value |
$0 |
$0 |
$0 |
$6,924,082 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
12 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Minogue Michael R |
Chairman, President, CEO |
|
2020-08-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,883 |
210,746 |
|
- |
|
Sutter Martin P |
Director |
|
2020-08-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
750 |
185,510 |
|
- |
|
Sutter Martin P |
Director |
|
2020-08-19 |
4 |
AS |
$312.38 |
$234,285 |
D/D |
(750) |
186,260 |
|
3% |
|
Sutter Martin P |
Director |
|
2020-08-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
750 |
187,010 |
|
- |
|
Sutter Martin P |
Director |
|
2020-08-18 |
4 |
AS |
$311.99 |
$233,993 |
D/D |
(750) |
187,760 |
|
3% |
|
Began Marc A |
VP & General CounselOfficer |
|
2020-08-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,624 |
|
1% |
|
Sutter Martin P |
Director |
|
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
188,510 |
|
- |
|
Rose Eric A Md |
Director |
|
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
14,475 |
|
- |
|
Thomas Paul |
Director |
|
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
7,191 |
|
- |
|
Van Gorder Chris |
Director |
|
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
6,752 |
|
- |
|
Puhy Dorothy E |
Director |
|
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
7,869 |
|
- |
|
Rivet Jeannine M |
Director |
|
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
661 |
8,660 |
|
- |
|
Thomas Paul |
Director |
|
2020-08-10 |
4 |
AS |
$303.41 |
$606,820 |
D/D |
(2,000) |
6,530 |
|
-1% |
|
Van Gorder Chris |
Director |
|
2020-08-07 |
4 |
D |
$314.98 |
$166,939 |
D/D |
(530) |
6,091 |
|
- |
|
Puhy Dorothy E |
Director |
|
2020-08-07 |
4 |
D |
$314.98 |
$139,851 |
D/D |
(444) |
7,208 |
|
- |
|
Rose Eric A Md |
Director |
|
2020-08-07 |
4 |
D |
$314.98 |
$132,922 |
D/D |
(422) |
13,814 |
|
- |
|
Sutter Martin P |
Director |
|
2020-08-07 |
4 |
D |
$314.98 |
$122,842 |
D/D |
(390) |
187,849 |
|
- |
|
Thomas Paul |
Director |
|
2020-08-07 |
4 |
D |
$314.98 |
$122,842 |
D/D |
(390) |
8,530 |
|
- |
|
Puhy Dorothy E |
Director |
|
2020-07-15 |
4 |
AS |
$275.00 |
$2,062,500 |
D/D |
(7,500) |
7,652 |
|
-4% |
|
Puhy Dorothy E |
Director |
|
2020-06-05 |
4 |
AS |
$250.00 |
$1,875,000 |
D/D |
(7,500) |
15,152 |
|
15% |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
600 |
30,855 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
9,380 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,476 |
39,043 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,567 |
231,629 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,033 |
124,932 |
|
- |
|
740 Records found
|
|
Page 8 of 30 |
|
|